S
Sonoval
sonoval.com
Website unreachable since Oct 19, 2026
Sonoval is developing novel anticancer therapies targeting lymphomas and solid tumors through dual mechanisms that enhance tumor cell apoptosis and inhibit tumor growth. These therapies aim to improve treatment efficacy and patient outcomes in oncology by addressing the limitations of current cancer treatments.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$73.7KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Sonoval is developing novel anticancer therapies targeting lymphomas and solid tumors through dual mechanisms that enhance tumor cell apoptosis and inhibit tumor growth. These therapies aim to improve treatment efficacy and patient outcomes in oncology by addressing the limitations of current cancer treatments.